FindTrial
Sign In

Synthetic ECV as a Myocardial Fibrosis Biomarker without Blood Sampling: A Systematic Review and Meta-analysis

Synthetic ECV as a Myocardial Fibrosis Biomarker without Blood Sampling: A Systematic Review and Meta-analysis - Synthetic ECV as a Myocardial Fibrosis Biomarker without Blood Sampling: A Systematic Review and Meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000055257
Enrollment
Unknown
Registered
2024-08-16
Start date
2024-08-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who undergo Cardiac MR or CT

Interventions

None listed

Sponsors

Department of Diagnostic Radiology, Yokohama City University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We include articles describing retrospective and prospective observational studies, and randomized controlled trials. We include studies meeting the following criteria: enrolled patients underwent cardiac MRI or CT.

Exclusion criteria

Exclusion criteria: We excluded case reports, case series, animal studies

Design outcomes

Primary

MeasureTime frame
correlation coefficient and mean absolute difference between synthetic and laboratory ECV—

Countries

Japan

Contacts

Public ContactNaofumi Yasuda

Yokohama City University Graduate School of Medicine Department of Diagnostic Radiology

yasuda.nao.mz@yokohama-cu.ac.jp+81-45-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026